Synthetic hydroxyapatite in pharmaceutical applications

Ceramics International

Volumn 42, Issue 2, 2016, Pages 2472-2487

  Kolmas, Joanna ^a   Krukowski, Sylwester ^a   Laskus, Aleksandra ^a   Jurkitewicz, Maria ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Carrier; Drug delivery systems; Hydroxyapatite; Multifunctional implant; Pharmacy

Indexed keywords

BIOCHEMISTRY; BIOCOMPATIBILITY; BONE; MEDICINE; NANOCRYSTALS; TISSUE;

CARRIER; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; PHARMACEUTICAL APPLICATIONS; PHARMACEUTICAL SCIENCE; PHARMACY; REGENERATIVE MEDICINE; SYNTHETIC HYDROXYAPATITE;

HYDROXYAPATITE;

EID: 84955200249     PISSN: 02728842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ceramint.2015.10.048     Document Type: Article

References (175)

1. S.V. Dorozhkin Calcium orthophosphate-based bioceramics Materials 6 9 2013 3840 3942
2. S. Bose, S. Tarafder, and A. Bandyopadhayay Hydroxyapatite coatings for metallic implants M. Mucalo, Hydroxyapatite (HAp) for Biomedical Applications 2015 Woodhead Publishing series in Biomaterials Cambridge, UK 143 159
3. Q. Liu, S. Huang, J.P. Matinlinna, Z. Chen, and H. Pan Insight into biological apatite: physiochemical properties and preparation approaches Biomed. Res. Int. 2013 2013 1 13
4. S.V. Dorozhkin Calcium orthophosphates in nature, biology and medicine Materials 2 2 2009 399 498
5. F. Peng, E. Veilleux, M. Schmidt, and M. Wei Synthesis of hydroxyapatite nanoparticles with tailorable morphologies and carbonate substitutions using a wet precipitation method J. Nanosci. Nanotechnol. 12 3 2012 2774 2782
6. M. Šupova Substituted hydroxyapatites for biomedical applications: a review Ceram. Int. 41 2015 9203 9231
7. J. Kolmas, E. Groszyk, and D. Kwiatkowska-Rózycka Substituted hydroxyapatite with antibacterial properties Biomed. Res. Int. 2014 2014 1 14 178123
8. M.P. Ginebra, C. Canal, M. Espagnol, D. Pastorino, and E.B. Montufar Calcium phosphate cements as drug delivery materials Adv. Drug Deliv. Rev. 64 2012 1090 1110
9. S. Bose, S. Tarafder, J. Edgington, and A. Bandyopadhyay Calcium phosphate ceramics in drug delivery J. Miner. Met. Mater. Soc. 63 4 2011 93 98
10. A.K. Jain, and R. Panchagnula Skeletal drug delivery systems Int. J. Pharm. 206 2000 1 12
11. D. Loca, J. Locs, A. Dubnika, V. Zalite, and L. Berzina-Cimdina Porous hydroxyapatite for drug delivery M. Mucalo, Hydroxyapatite (HAp) for Biomedical Applications 2015 Woodhead Publishing series in Biomaterials Cambridge, UK 189 209
12. Q. He, L. Pan, Y. Wang, and F.C. Meldrum Bioinspired synthesis of large-pore, mesoporous hydroxyapatite nanocrystals for the controlled release of large pharmaceutics Cryst. Growth Des. 15 2015 723 731
13. R.G.G. Russell Bisphosphonates from bench to bedside Ann. N.Y. Acad. Sci. 1068 2006 367 401
14. J.S. Chen, and P.N. Sambrook Antiresorptive therapies for osteoporosis: a clinical overview Nat. Rev. Endocrinol. 8 2012 81 91
15. J. Kulak Jr., C.A. Moreira Kulak, and H.S. Taylor SERMs in the prevention and treatment of postmenopausal osteoporosis: an update Arq. Bras. Endocrinol. Metab. 54 2 2010 200 205
16. S. Panzavolta, P. Torricelli, B. Bracci, M. Fini, and A. Bigi Functionalization of biomimetic calcium phosphate bone cements with alendronate J. Inorg. Biochem. 104 2010 1099 1106
17. S. Panzavolta, P. Torricelli, B. Bracci, M. Fini, and A. Bigi Alendronate and pamidronate calcium phosphate bone cements: Setting properties and in vitro response of osteoblast and osteoclast cells J. Inorg. Biochem. 103 2009 101 106
18. E. Boanini, P. Torricelli, M. Gazzano, M. Fini, and A. Bigi The effect of alendronate doped calcium phosphates on bone cells activity Bone 51 2012 944 952
19. E. Boanini, P. Torricelli, M. Gazzano, R. Giardino, and A. Bigi Alendronate-hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast-like cells Biomaterials 29 2008 790 796
20. A. Bigi, E. Boanini, Ch Capuccini, M. Fini, I.N. Mihailescu, C. Ristoscu, F. Sima, and P. Torricelli Biofunctional alendronate-hydroxyapatite thin films deposited by matrix assisted pulsed laser evaporation Biomaterials 30 2009 6168 6177
21. R. Bosco, M. Iafisco, A. Tampieri, J.A. Jansen, S.C.G. Leeuwenburgh, and J.J.J.P. van den Beucken Hydroxyapatite nanocrystals functionalized with alendronate as bioactive components for bone implant coatings to decrease osteoclastic activity Appl. Surf. Sci. 328 2015 516 524
22. Z. Shen, T. Yu, and J. Ye Microstructure and properties of alendronate-loaded calcium phosphate cement Mater. Sci. Eng. C 42 2014 303 311
23. V. Schnitzler, F. Fayon, Ch Despas, I. Khairoun, Ch Mellier, T. Rouillon, D. Massiot, A. Walcarius, P. Janvier, O. Gauthier, G. Montavon, J.M. Bouler, and B. Bujoli Investigation of alendronate-doped apatitic cements as a potential technology for the prevention of osteoporotic hip fractures: critical influence of the drug introduction mode on the in vitro cement properties Acta Biomater. 7 2011 759 770
24. S. Niu, X. Cao, Y. Zhang, Q. Zhu, and J. Zhu The inhibitory effect of alendronate-hydroxyapatite composite coating on wear debris-induced peri-implant high bone turnover J. Surg. Res. 179 2013 E107 E115
25. N. Vargas-Becerril, C. Patino-Carachure, L.M. Rodriguez-Lorenzo, and L. Tellez-Juardo Synthesis of hybrid compounds apatite-alendronate by reactive milling and effects on the structure and morphology of the apatite phase Ceram. Int. 39 2013 3921 3929
26. W. Ch., Y.P. Kim, H.J. Yun, Y.S. Lee, I.K. Hwang, S. Kwon, and Ch Lee In situ fabrication of alendronate-loaded calcium phosphate microspheres: Controlled release for inhibition of osteoclastogenesis J. Control. Release 147 2010 45 53
27. J.H. Lee, I.H. Ko, S.H. Jeon, J.H. Chae, and J.H. Chang Micro-structured hydroxyapatite microspheres for local delivery of alendronate and BMP-2 carriers Mater. Lett. 105 2013 136 139
28. W. Huang, Y. Wang, L. Ren, Ch Du, and X. Shi A novel PHBV/HA microsphere releasing system loaded with alendronate Mater. Sci. Eng. C 29 2009 2221 2225
29. Ch Chen, M. Xia, L. Wu, Ch Zhou, and F. Wang Modeling the interaction of seven bisphosphonates with the hydroxyapatite(100) face J. Mol. Model. 18 2012 4007 4012
30. M. Othmani, A. Aissa, Ch.G. Bac, F. Rachdi, and M. Debbabi Surface modification of calcium hydroxyapatite by grafting of etidronic acid Appl. Surf. Sci. 274 2013 151 157
31. F. Errassifi, S. Sarda, A. Barroug, A. Legrouri, H. Sfihi, and C. Rey Infrared, Raman and NMR investigation of risedronate adsorption on nanocrystalline apatites J. Colloid Interface Sci. 420 2014 101 111
32. D. Li, Y. Zhu, and Z. Liang Alendronate functionalized mesoporous hydroxyapatite nanoparticles for drug delivery Mater. Res. Bull. 48 2013 2201 2204
33. P. Pascaud, F. Errassifi, F. Brouillet, S. Sarda, A. Barroug, A. Legrouri, and C. Rey Adsorption on apatitic calcium phosphates for drug delivery: interaction with bisphosphonate molecules J. Mater. Sci. Mater. Med. 25 2014 2373 2381
34. W. Huang, W. Liu, Z. She, H. Wu, and X. Shi Alendronate decorated nano hydroxyapatite in mesoporous silica: Cytotoxicity and osteogenic properties Appl. Surf. Sci. 257 2011 9757 9761
35. E. Boanini, P. Torricelli, M. Gazzano, M. Fini, and A. Bigi The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro Biomaterials 33 2012 722 730
36. E. Boanini, P. Torricelli, M. Gazzano, E.D. Bella, M. Fini, and A. Bigi Combined effect of strontium and zoledronate on hydroxyapatite structure and bone cell responses Biomaterials 35 2014 5619 5626
37. E. Boanini, P. Torricelli, F. Sima, E. Axente, M. Fini, I.N. Mihailescu, and A. Bigi Strontium and zoledronate hydroxyapatites graded composite coatings for bone prostheses J. Colloid Interface Sci. 448 2015 1 7
38. B. Peter, D.P. Pioletti, S. Laïb, B. Bujoli, P. Pilet, P. Janvier, J. Guicheux, P.Y. Zambelli, J.M. Bouler, and O. Gauthier Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration Bone 36 2005 52 60
39. C.M. Murphy, A. Schindeler, J.P. Gleeson, N.Y.C. Yu, L.C. Cantrill, K. Mikulec, L. Peacock, F.J. O'Brien, and D.G. Little A collagen-hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates Acta Biomater. 10 2014 2250 2258
40. Y. Gao, S. Zou, X. Liu, Ch Bao, and J. Hu The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats Biomaterials 30 2009 1790 1796
41. D.K. Khajuria, R. Razdan, and D.R. Mahapatra Development, in vitro and in vivo characterization of zoledronic acid functionalized hydroxyapatite nanoparticle based formulation for treatment of osteoporosis in animal model Eur. J. Pharm. Sci. 66 2015 173 183
42. G.H. Nancollas, R. Tang, R.J. Phipps, Z. Henneman, S. Gulde, W. Wu, A. Mangood, R.G.G. Russell, and F.H. Ebetino Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite Bone 38 2006 617 627
43. M.A. Lawson, Z. Xia, B.L. Barnett, J.T. Triffitt, R.J. Phipps, J.E. Dunford, R.M. Locklin, F.H. Ebetino, and R.G.G. Russel Differences between bisphosphonates in binding affinities for hydroxyapatite J. Biomed. Mater. Res. Part B Appl. Biomater. 92B 2010 149 155
44. K. McLeod, S. Kumar, R.St.C. Smart, N. Dutta, N.H. Voelcker, G.I. Anderson, and R. Sekel XPS and bioactivity study of the bisphosphonate pamidronate adsorbed onto plasma sprayed hydroxyapatite coatings Appl. Surf. Sci. 253 2006 2644 2651
45. X. Zhang, J. Hu, Y. Li, G. Yin, and E. Luo Effects of ibandronate-hydroxyapatite on resorptive activity of osteoclasts Arch. Med. Sci. 7 1 2011 53 60
46. R.S. Hayden, M. Vollrath, and D.L. Kaplan Effects of clodronate and alendronate on osteoclast and osteoblast co-cultures on silk-hydroxyapatite films Acta Biomater. 10 2014 486 493
47. E. Luo, X. Liu, S.C. Wei, X.X. Cai, and J. Hu Osteoblast adhesion to clodronate-hydroxyapatite composite Appl. Surf. Sci. 255 2008 308 311
48. J. Kolmas, M. Sobczak, E. Olędzka, G. Nałęcz-Jawecki, and C. Dębek Synthesis, characterization and in vitro evaluation of new composite bisphosphonate delivery systems Int. J. Mol. Sci. 15 2014 16831 16847
49. I. Pelayo, J. Haya, J.J. De la Cruz, C. Secco, J.I. Bugella, J.L. Diaz, J.M. Bajo, and M. Repolles Raloxifene plus ossein-hydroxyapatite compound versus raloxifene plus calcium carbonate to control bone loss in postmenopausal women: a randomized trial Menopause 15 6 2008 1132 1138
50. L. Meme, A. Santarelli, G. Marzo, M. Emanuelli, P.F. Nocini, D. Bertossi, A. Putignano, M. Dioguardi, L. Lo Muzio, and F. Bambini Novel hydroxyapatite biomaterial covalently linked to raloxifene Int. J. Immunopathol. Pharmacol. 27 3 2014 437 444
51. T.M. Willson, B.R. Henke, T.M. Momtahen, D.T. Garrison, L.B. Moore, N.G. Geddie, and P.G. Baer Bone targeted drugs 2. Synthesis of estrogens with hydroxyapatite affinity Bioorg. Med. Chem. Lett. 6 9 1996 1047 1050
52. A. Yaganawa, Nasally administrable peptide compositions on hydroxyapatite carriers. US Patent No. 5574006:1996.
53. M. Emoto, Y. Naganuma, B. Choijamts, T. Ohno, H. Yoshihisa, N. Kanomata, T. Kawarabayashi, and M. Aizawa Novel chemoembolization using calcium phosphate ceramic microsphere incorporating TNP-470, an anti-angiogenic agent Cancer Sci. 101 4 2010 984 990
54. I. Urushizaki Palliative therapy in cancer. Side effects by anticancer drugs and their treatments Cancer Chemother. Pharmacol. 17 9 1990 1959 1969
55. A. Barroug, and M.J. Glimcher Hydroxyapatite crystals as a local delivery system for cisplatin: adsorption and release of cisplatin in vitro J. Orthop. Res. 20 2 2002 274 280
56. A. Barroug, L.T. Kuhn, L.C. Gerstenfeld, and M.J. Glimcher Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release J. Orthop. Res. 22 4 2004 703 708
57. C. Marques, A. Ficai, J.M.F. Ferreira, D. Ficai, and M. Sonmez Multifunctional materials for bone cancer treatment Int. J. Nanomed. 9 1 2014 2713 2725
58. A. Uchida, Y. Shinto, N. Araki, and K. Ono Slow release of anticancer drugs from porous calcium hydroxyapatite ceramic J. Orthop. Res. 10 3 1992 440 445
59. A. Uchida, Y. Shinto, N. Araki, and K. Ono Development of a slow release system of anti-cancer drugs retained in calcium-hydroxyapatite ceramic Cancer Chemother. Pharmcol. 16 9 1989 3231 3235
60. J.C. Yang, Q.S. Yin, J. Lin, H.Y. Huang, H.W. Ding, Y. Zhang, and J. Li Preparation of cisplatin-impregnated coral hydroxyapatite drug delivery system J. South. Med. Univ. 27 3 2007 283 285
61. Y. Shinto, A. Uchida, N. Araki, and K. Ono Application of a slow release system of anti-cancer drug retained in calcium hydroxyapatite ceramic against experimental bone and soft tissue sarcoma Cancer Chemother. Pharmacol. 18 2 1991 221 226
62. D.J. Netz, P. Sepulveda, V.C. Pandolfelli, A.C. Spadaro, J.B. Alencastre, M.V. Bentley, and J.M. Marchetti Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system Int. J. Pharmacol. 213 1-2 2001 117 125
63. K. Yamamura, H. Iwata, T. Osada, T. Yotsuyanagi, and T. Nabeshima Anticancer effects of adriamycin-loaded hydroxyapatite implants determined in a Swarm rat chondrosarcoma model Jpn. J. Pharmacol. 65 3 1994 289 291
64. K. Yamamura, H. Iwata, T. Osada, T. Yotsuyanagi, and T. Nabeshima Antitumor effects and distribution of adriamycin incorporated into hydroxyapatite implants in a cancer rat model bearing swarm rat chondrosarcoma Jpn. J. Pharmacol. 66 4 1994 433 438
65. M. Itokazu, S. Kumazawa, E. Wada, and Y. Wenyi Sustained release of adriamycin from implanted hydroxyapatite blocks for the treatment of experimental osteogenic sarcoma in mice Cancer Lett. 107 1 1996 11 18
66. J. Venkatesan, R. Pallela, I. Bhatnagar, and S.K. Kim Chitosan-amylopectin/hydroxyapatite and chitosan-chondroitin sulphate/hydroxyapatite composite scaffolds for bone tissue engineering Int. J. Biol. Macromol. 51 5 2012 1033 1042
67. M. Itokazu, M. Esaki, K. Yamamoto, T. Tanemori, and T. Kasai Local drug delivery system using ceramics: vacuum method for impregnating a chemotherapeutic agent into a porous hydroxyapatite block J. Mater. Sci. 10 4 1999 249 252
68. M. Itokazu, T. Sugiyama, T. Ohno, E. Wada, and Y. Katagiri Development of porous apatite ceramic for local delivery of chemotherapeutic agents J. Biomed. Mater. Res. 39 4 1998 536 538
69. M. Betsiou, G. Bantsis, I. Zoi, and C. Sikalidis Adsorption and release of gemcitabine and oxaliplatin by hydroxyapatite Ceram. Int. 38 2012 2719 2724
70. D. Zhang, A. Tian, X. Xue, M. Wang, B. Qiu, and A. Wu The effect Of temozolomide/poly(lactide-co-glycolide)(PLGA)/nano-hydroxyapatite microspheres on Glioma U87 cells behavior Int. J. Mol. Sci. 13 2012 1109 1125
71. A.E. Burgos, J.C. Belchior, and R.D. Sinisterra Controlled release of rhodium (II) carboxylates and their association complexes with cyclodextrins from hydroxyapatite matrix Biomaterials 23 2002 2519 2526
72. K. Watanabe, Y. Nishio, R. Makiura, A. Nakahira, and C. Kojima Paclitaxel-loaded hydroxyapatite/collagen hybrid gels as drug delivery systems for metastatic cancer cells Int. J. Pharm. 446 2013 81 86
73. T. Abe, M. Sakane, T. Ikoma, T. Tonegawa, T. Yoshioka, J. Tanaka, and N. Ochiai Key Eng. Mater. 330-332 2007 1343 1346
74. A. El-Ghannam, K. Ricci, A. Malkawi, K. Jahed, K. Vedantham, H. Wyan, L.D. Allen, and D. Dréau A ceramic-based anticancer drug delivery system to treat breast cancer J. Mater. Sci. Mater. Med. 21 9 2010 2701 2710
75. M. Diefenbeck, T. Mückley, and G.O. Hofmann Prophylaxis and treatment of implant-related infections by local application of antibiotics Injury 37 2006 95 104
76. G.-J.A. Ter Boo, D.W. Grijpma, T.F. Moriarty, R.G. Richards, and D. Eglin Antimicrobial delivery systems for local infection prophylaxis in orthopedic - and trauma surgery Biomaterials 52 2015 113 125
77. J. Klekamp, J. Dawson, D.W. Haas, D. DeBoer, and M. Christie The use of vancomycin and tobramycin in acrylic bone cement: biomechanical effects and elution kinetics for use in joint arthroplasty J. Arthroplast. 14 3 1999 339 346
78. V. Uskoković Nanostructured platforms for the sustained and local delivery of antibiotics in the treatment of osteomyelitis Crit. Rev. Ther. Drug Carrier Syst. 32 1 2015 1 59
79. M.A. Rauschmann, T.A. Wichelhaus, V. Stirnal, E. Dingeldein, L. Zichner, R. Schnettler, and V. Alt Nanocrystalline hydroxyapatite and calcium sulphate as biodegradable composite carrier material for local delivery of antibiotics in bone infections Biomaterials 26 2005 2677 2684
80. U. Joosten, A. Joist, G. Gosheger, U. Liljenqvist, B. Brandt, and Ch von Eiff Effectiveness of hydroxyapatite - vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis Biomaterials 26 2005 5251 5258
81. M.P. Ginebra, T. Traykova, and J.A. Planell Calcium phosphate cements as bone drug delivery systems J. Control. Release 113 2006 102 110
82. J.C. Chai, N. Hornez, C. Blanchemain, M. Neut, H.F. Descamps, and H.F. Hildebrand Antibacterial activation of hydroxyapatite (HA) with controlled porosity by different antibiotics Biomol. Eng. 24 2007 510 514
83. M. Yu, K. Zhou, Z. Li, and D. Zhang Preparation, characterization and in vitro gentamicin release of porous HA microspheres Mater. Sci. Eng. C 45 2014 306 312
84. M. Yu, K. Zhou, F. Zhang, and D. Zhang Porous HA microspheres as drug delivery: effects of porosity and pore structure on drug loading and in vitro release Ceram. Int. 40 2014 12617 12621
85. J. Schnieders, U. Gbureck, R. Thull, and T. Kissel Controlled release of gentamicin from calcium phosphate-poly(lactic acid-co-glycolic acid) composite bone cement Biomaterials 27 2006 4239 4249
86. U. Joosten, A. Joist, T. Frebel, B. Brandt, S. Diederichs, and C. von Eiff Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo Biomaterials 25 2004 4287 4295
87. S. Padilla, R.P. del Real, and M. Vallet-Regí In vitro release of gentamicin from OHAp/PEMA/PMMA samples J. Control. Release 83 2002 343 352
88. C.H.D. Chen, C.C. Chen, M.Y. Shie, C.H. Huang, and S.J. Ding Controlled release of gentamicin from calcium phosphate/alginate bone cement Mater. Sci. Eng. C 31 2011 334 341
89. Y. Wang, X. Wang, K. Wei, N. Zhao, S. Zhang, and J. Chen Fabrication, characterization and long-term in vitro release of hydrophilic drug using PHBV/HA composite microspheres Mater. Lett. 61 2007 1071 1076
90. Y.J. Guo, T. Long, W. Chen, C.Q. Ning, and Z.A. Zhu Bactericidal property and biocompatibility of gentamicin-loaded mesoporous carbonated hydroxyapatite microspheres Mater. Sci. Eng. C 33 2013 3583 3591
91. M. Pourbaghi-Masouleh, S. Hesaraki, A. Zamanian, and A. Khanlarkhani Gentamicin-PEGylated poor crystalline carbonated hydroxyapatite submicron particles Mater. Lett. 113 2013 130 133
92. M. Sivakumar, and K. Panduranga Rao Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite-gelatin composite microspheres Biomaterials 23 2002 3175 3181
93. M. Sivakumar, and K. Panduranga Rao Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite-alginate composite microspheres J. Biomed. Mater. Res. A 65 2003 222 228
94. M. Sivakumar, I. Manjubala, and K. Panduranga Rao Preparation, characterization and in vitro release of gentamicin from coralline hydroxyapatite-chitosan composite microspheres Carbohydr. Polym. 49 2002 281 288
95. M. Baro, E. Sanchez, A. Delgado, A. Perera, and C. Evora In vitro-in vivo characterization of gentamicin bone implants J. Control. Release 83 2002 353 364
96. A. Belcarz, A. Zima, and G. Ginalska Biphasic mode of antibacterial action of aminoglycoside antibiotics-loaded elastic hydroxyapatite-glucan composite Int. J. Pharm. 454 2013 285 295
97. M. Teller, U. Gopp, H.G. Neumann., and K.D. Künn Release of gentamicin from bone regenerative materials: an in vitro study J. Biomed. Mater. Res. B 81 2007 23 29
98. C.C. Yang, C.C. Lin, J.W. Liao, and S.K. Yen Vancomycin-chitosan composite deposited on postporous hydroxyapatite coated Ti6Al4V implant for drug controlled release Mater. Sci. Eng. C 33 2013 2203 2212
99. C. Makarov, V. Cohen, A. Raz-Pasteur, and I. Gotman In vitro elution of vancomycin from biodegradable osteoconductive calcium phosphate-polycaprolactone composite beads for treatment of osteomyelitis Eur. J. Pharm. Sci. 62 2014 49 56
100. D. Loca, M. Sokolova, J. Locs, A. Smirnova, and Z. Irbe Calcium phosphate bone cements for local vancomycin delivery Mater. Sci. Eng. C 49 2015 106 113
101. P. Layrolle Incorporation of different antibiotics into carbonated hydroxyapatite coatings on titanium implants, release and antibiotic efficacy J. Control. Release 99 2004 127 137
102. J. Yu, X. Chu, Y. Cai, P. Tong, and J. Yao Preparation and characterization of antimicrobial nano-hydroxyapatite composites Mater. Sci. Eng. C 37 2014 54 59
103. S. Leprêtre, F. Chai, J.Ch Hornez, G. Vermet, Ch Neut, M. Descamps, H.F. Hildebrand, and B. Martel Prolonged local antibiotics delivery from hydroxyapatite functionalized with cyclodextrin polymers Biomaterials 30 2009 6086 6093
104. J.L. Jiang., Y.F. Li, T.L. Fang, J. Zhou, X.L. Li, Y.C. Wang, and J. Dong Vancomycin-loaded nano-hydroxyapatite pellets to treat MRSA-induced chronic osteomyelitis with bone defect in rabbits Inflamm. Res. 61 2012 207 215
105. T. Saito, R. Takeuchi, K. Hirakawa, N. Nagata, T. Yoshida, T. Koshino, K. Okuda, M. Takema, and T. Hori Slow-releasing potential of vancomycin-loaded porous hydroxyapatite blocks implanted into MRSA osteomyelitis J. Biomed. Mater. Res. 63 2002 245 251
106. J. Zhang, C. Wang, J. Wang, Y. Qu, and G. Liu In vivo drug release and antibacterials properties of vancomycin loaded hydroxyapatite/chitosan composite Drug Deliv. 19 2012 264 269
107. X. Lian, H. Liu, X. Wan, S. Xu, F. Cui, and X. Bai Antibacterial and biocompatible properties of vancomycin-loaded nano-hydroxyapatite/collagen/poly(lactic acid) bone substitute Prog. Nat. Sci. Mater. Int. 23 2013 549 556
108. F.J. Martinez-Vazkez, M.V. Cabanas, J.L. Paris, D. Lozano, and M. Vallet-Regi Fabrication of novel Si-doped hydroxyapatite/gelatin scaffolds by rapid prototyping for drug delivery and bone regeneration Acta Biomater. 15 2015 200 209
109. X. Li, J. Xu, T.M. Filion, D.C. Ayers, and J. Song pHEMA-nHA encapsulation and delivery of vancomycin and rhBMP-2 enhances its role as a bone graft substitute Clin. Orthop. Relat. Res. 471 2013 2540 2547
110. M. Lilja, J.H. Sorensen, U. Brohede, M. Astrand, P. Procter, J. Arnoldi, H. Steckel, and M. Stromme Drug loading and release of tobramycin from hydroxyapatite coated fixation pins J. Mater. Sci. Mater. Med. 24 2013 2265 2274
111. J.H. Sorensen, M. Lilja, T.C. Sorensen, M. Astrand, M. Procter, S. Fuchs, M. Stromme, and H. Steckel Biomechanical and antibacterial properties of tobramycin loaded hydroxyapatite coated fixation pins J. Biomed. Mater. Res. B 102 2014 1381 1392
112. B. Wang, M. Lilja, T. Ma, J. Sorensen, H. Steckel, R. Ahuja, and M. Stromme Theoretical and experimental study of the incorporation of tobramycin and strontium-ions into hydroxyapatite by means of co-precipitation Appl. Surf. Sci. 314 2014 376 383
113. M. Stigter, K. de Groot, and P. Layrolle Incorporation of tobramycin into biomimetic hydroxyapatite coating on titanium Biomaterials 23 2002 4143 4153
114. D.J. Moojen, H.C. Vogely, A. Fleer, P.G.J. Nikkels, P.A. Higham, A.J. Verbout, R.M. Castelein, and W.J.A. Dhert Prophylaxis of infection and effects on osseointegration using a tobramycin-periapatite coating on titanium implants - an experimental study in the rabbit J. Orthopaed. Res. 27 2009 710 716
115. S. Nardecchia, M.C. Gutierrez, M. Concepcion Serrano, M. Dentini, A. Barbetta, M.L. Ferrer, and F. del Monte In situ precipitation of amorphous calcium phosphate and ciprofloxacin crystals during the formation of chitosan hydrogels and its application for drug delivery purposes Langmuir 28 2012 15937 15946
116. C. Castro, E. Sanchez, A. Delgado, I. Soriano, P. Nunez, M. Baro, A. Perera, and C. Evora Ciprofloxacin implants for bone infections. In vitro-vivo characterization J. Control. Release 93 2003 341 354
117. S. Sasikumar Effect of particle size of calcium phosphate based bioceramic drug delivery carrier on the release kinetics of ciprofloxacin hydrochloride: an in vitro study Front. Mater. Sci. 7 2013 261 268
118. M.P. Ferraz, A.Y. Mateus, J.C. Sousa, and F.J. Monteiro Nanohydroxyapatite microspheres as delivery system for antibiotics: release kinetics, antimicrobial activity, and interaction with osteoblasts J. Biomed. Mater. Res. A 81 2007 994 1004
119. W. Paul, and C.P. Sharma Antibiotic loaded hydroxyapatite osteoconductive implant material - in vitro release study J. Mater. Sci. Lett. 14 1995 1792 1794
120. A.C. Querioz, J.D. Santos, F.J. Monteiro, I.R. Gibson, and J.C. Knowles Adsorption and release studies of sodium ampicillin from hydroxyapatite and glass-reinforced hydroxyapatite composites Biomaterials 22 2001 1393 1400
121. S. Hesaraki, F. Moztarzadeh, R. Nemati, and N. Nezafati Preparation and characterization of calcium sulfate-biomimetic apatite nanocomposites for controlled release of antibiotics J. Biomed. Mater. Res. B 91 2009 651 661
122. M.K. Kang, S.B. Lee, S.K. Moon, K.M. Kim, and K.N. Kim The biomimetic apatite-cefalotin coatings on modified titanium Dent. Mater. J. 31 2012 98 105
123. J. Forsgren, U. Brohede, M. Stromme, and H. Engqvist Co-loading of bisphosphonates and antibiotics to a biomimetic hydroxyapatite coating Biotechnol. Lett. 33 2011 1265 1268
124. H. Liu, L. Zhang, P. Shi, S. Zou, Y. Zuo, and Y. Li Hydroxyapatite/polyurethane scaffold incorporated with drug-loaded ethyl cellulose microspheres for bone regeneration J. Biomed. Mater. Res. B 95 2010 36 46
125. B. Kundu, A. Lemos, C. Soundrapandian, P.S. Sen, S. Datta, J.M.F. Ferreira, and D. Basu Development of porous Hap and β-TCP scaffolds by starch consolidation with foaming method and drug-chitosan bilayered scaffold based drug delivery system J. Mater. Sci. Mater. Med. 21 2010 2955 2969
126. B. Kundu, C. Soundrapandian, S.K. Nandi, P. Mukherjee, N. Dandapat, S. Roy, S. Datta, T.K. Mandal, D. Basu, and R.N. Bhattacharya Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial Pharm. Res. 27 2010 1659 1676
127. S. Cazalbou, G. Bertrand, and C. Drouet Tetracycline-loaded biomimetic apatite: an adsorption study J. Phys. Chem. B 119 2015 3014 3024
128. D. Pastorino, C. Canal, and M.P. Ginebra Drug delivery from injectable calcium phosphate foams by tailoring themacroporosity - drug interaction Acta Biomater. 12 2015 250 259
129. H.W. Kim, J.C. Knowles, and H.E. Kim Porous scaffolds of gelatin-hydroxyapatite nanocomposites obtained by biomimetic approach: characterization and antibiotic drug release J. Biomed. Mater. Res. B 74 2005 686 698
130. A. Ratier, I.R. Gibson, S.M. Best, M. Freche, J.L. Lacout, and F. Rodriguez Setting characteristics and mechanical behavior of a calcium phosphate bone cement containing tetracycline Biomaterials 22 2001 897 901
131. B. Čolović, S. Pašalić, and V. Jokanović Influence of hydroxyapatite pore geometry on tigecycline release kinetics Ceram. Int. 38 2012 6181 6189
132. A. Dashti, D. Ready, V. Salih, J.C. Knowles, J.E. Barralet, M. Wilson, N. Donos, and S.N. Nazhat In vitro antibacterial efficacy of tetracycline hydrochloride adsorbed onto Bio - Oss® bone graft J. Biomed. Mater. Res. B 93 2010 394 400
133. M. Kaya, G. Şimşek-Kaya, N. Gürsan, E. Kireççi, E. Day, and B. Gündogdu Local treatment of chronic osteomyelitis with surgical debridement and tigecycline-impregnated calcium hydroxyapatite: an experimental study Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 113 2012 340 347
134. X. Wang, H. Xu, Y. Zhao, S. Wang, H. Abe, M. Naito, Y. Liu, and G. Wang Poly (lactide-co-glycolide) encapsulated hydroxyapatite microspheres for sustained release of doxycycline Mater. Sci. Eng. B 177 2012 367 372
135. M. HamdanAlkhraisat, C. Rueda, J. Cabrejos-Azama, J. Lucas-Aparicio, F. TamimiMariño, J. Torres García-Denche, L. Blanco Jerez, U. Gbureck, and E. Lopez Cabarcos Loading and release of doxycycline hyclate from strontium-substituted calcium phosphate cement Acta Biomater. 6 2010 1522 1528
136. M. Vucomanović, T. Zavašnik-Bergant, I. Bračko, S.D. Škapin, N. Ignjatović, V. Radmilović, and D. Uskoković Poly (D,L-lactide-co-glycolide)/hydroxyapatite core-shell nanospheres Part 3: properties of hydroxyapatite nano-rods and investigation of a distribution of the drug within the composite Colloid. Surf. B 87 2011 226 235
137. D. Uskoković, and T.A. Desai Simultaneous bactericidal and osteogenic effect of nanoparticulate calcium phosphate powders loaded with clindamycin on osteoblasts infected with Staphylococcus aureus Mater. Sci. Eng. C 37 2014 210 222
138. D. Uskoković, S.S. Batarni, J. Schweicher, A. King, and T.A. Desai Effect of calcium phosphate particle shape and size on their antibacterial and osteogenic activity in the delivery of antibiotics in vitro Appl. Mater. Interface 5 2013 2422 2431
139. J. Fischer, A. Kolk, S. Wolfart, C. Pautke, P.H. Warnke, C. Plank, and R. Smeets J. Craniomaxillofac. Surg. 39 2011 54 64
140. V. Uskoković, and D.P. Uskoković Nanosized hydroxyapatite and other calcium phosphates: chemistry of formation and application as drug and gene delivery agents J. Biomed. Mater. Res B 96 1 2011 152 191
141. K. Tomoda, H. Ariizumi, T. Nakaji, and K. Makino Hydroxyapatite particles as drug carriers for proteins Colloids Surf. B 76 2010 226 235
142. W. Zhang, Y. Chai, X. Xu, Y. Wang, and N. Cao Rod-shaped hydroxyapatite with mesoporous structure as drug carriers for proteins Appl. Surf. Sci. 322 2014 71 77
143. X.-Y. Zhao, Y.-J. Zhu, F. Chen, B.-Q. Lu, and L. Wu Nanosheet-assembled hierarchical nanostructures of hydroxyapatite: surfactant-free microwave-hydrothermal rapid synthesis, protein/DNA adsorption and pH-controlled release Cryst. Eng. Comm 15 2013 206 212
144. W.-H. Lee, A.V. Zavgorodniy, C.-Y. Loo, and R. Rohanizadeh Synthesis and characterization of hydroxyapatite with different crystallinity: effects on protein adsorption and release J. Biomed. Mater. Res. A 100 6 2012 1539 1549
145. J.Y. Han, T.T.Y. Tan, and J.S.C. Loo Utilizing inverse micelle to synthesize calcium phosphate nanoparticles as nano-carriers J. Nanoparticle Res. 13 2011 3441 3454
146. C. Kojima, and K. Watanabe Adsorption and desorption of bioactive proteins on hydroxyapatite for protein delivery systems J. Drug Deliv. 2012 1 4 10.1155/2012/932461 ID 932461
147. W. Paul, J. Nesamony, and C.P. Sharma Delivery of insulin from hydroxyapatite ceramic microspheres: preliminary in vivo studies J. Biomed. Mater. Res. 61 4 2002 660 662
148. M. Iafisco, E. Varoni, M. Di Foggia, S. Pietronave, M. Fini, N. Roveri, L. Rimondini, and M. Prat Conjugation of hydroxyapatite nanocrystals with human immunoglobulin G for nanomedical applications Colloids Surf. B 90 2012 1 7
149. R.S. Pandey, S. Sahu, M.S. Sudheesh, J. Madan, M. Kumar, and V.K. Dixit Carbohydrate modified ultrafine ceramic nanoparticles for allergen immunotherapy Int. Immunopharmacol. 11 2011 925 931
150. S. Shiels, S. Oh, C. Bae, T. Guda, B. Singleton, D.D. Dean, J.C. Wenke, M.R. Appleford, and J.L. Ong Evaluation of BMP-2 tethered polyelectrolyte coatings on hydroxyapatite scaffolds in vivo J. Biomed. Mater. Res. B 100 7 2012 1782 1791
151. R. Rohanizadeh, and K. Chung Hydroxyapatite as a carrier for bone morphogenetic protein J. Oral Implantol. 37 6 2011 659 672
152. T. Crouzier, F. Sailhan, P. Becquart, R. Guillot, D. Logeart-Avramoglou, and C. Picart The performance of BMP-2 loaded TCP/HAP porous ceramic with a polyelectrolyte multilayer film coating Biomaterials 32 2011 7543 7554
153. G. Xie, J. Sun, G. Zhong, C. Liu, and J. Wei Hydroxyapatite nanoparticles as a controlled-release carrier of BMP-2: adsorption and release kinetics in vitro J. Mater. Sci. Mater. Med. 21 2010 1875 1880
154. W.J.E.M. Habraken, J.G.C. Wolke, and J.A. Jansen Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering Adv. Drug Deliv. Rev. 59 2007 234 248
155. M.H. Uddin, T. Matsumoto, S. Ishihara, A. Nakahira, M. Okazaki, and T. Sohmura Apatite containing aspartic acid for selective protein loading J. Dent. Res. 89 5 2010 488 492
156. D. Kozlova, S. Chermousova, T. Knuschke, J. Buer, A.M. Westendorf, and M. Epple Cell targeting by antibody-functionalized calcium phosphate nanoparticles J. Mater. Chem. 22 2012 396 404
157. C. Qi, Y.-J. Zhu, B.-Q. Lu, X.-Y. Zhao, J. Zhao, and F. Chen Hydroxyapatite nanosheet-assembled porous hollow microspheres: DNA-templated hydrothermal synthesis, drug delivery and protein adsorption J. Mater. Chem. 22 2012 22642 22650
158. J. Klesing, S. Chernousova, and M. Epple Freeze-dried cationic calcium phosphate nanorods as versatile carriers of nucleic acids (DNA, siRNA) J. Mater. Chem. 22 2012 199 204
159. S. Li, K. Wang, K.-C.A. Chang, M. Zong, J. Wang, Y.G. Cao, Y.H. Bai, T.M. Wei, and Z.R. Zhang Preparation and evaluation of nano-hydroxyapatite/poly(styrene-divinylbenzene) porous microspheres for aspirin carrier Sci. China Chem. 55 6 2012 1134 1139
160. M. Öner, E. Yetiz, E. Ay, and U. Uysal Ibuprofen release from porous hydroxyapatite tablets Ceram. Int. 37 2011 2117 2125
161. F. Shao, L. Liu, K. Fan, Y. Cai, and J. Yao Ibuprofen loaded porous calcium phosphate nanospheres for skeletal drug delivery system J. Mater. Sci. 47 2012 1054 1058
162. A.J. Melville, L. Rodriguez-Lorenzo, and J.S. Forsythe Effects of calcination temperature on the drug delivery behavior of Ibuprofen from hydroxyapatite powders J. Mater. Sci. Mater. Med. 19 2008 1187 1195
163. B. Palazzo, M.C. Sidotti, N. Roveri, A. Tampieri, M. Sandri, L. Bertolazzi, F. Galbusera, G. Dubini, P. Vena, and R. Contro Controlled delivery from porous hydroxyapatite grafts: an experimental and theoretical approach Mater. Sci. Eng. C 25 2005 207 213
164. K. Ishikawa, and Y. Iwamoto Effect of structure and composition on ibuprofen drug delivery by calcium phosphate nanocarriers Key Eng. Mater. 529-530 2012 495 500
165. Q. Xu, Y. Tanaka, and J.T. Czernuszka Encapsulation and release of a hydrophobic drug from hydroxyapatite coated liposomes Biomaterials 28 2007 2687 2694
166. S. Kommineni, S. Ahmad, P. Vengala, and C.V.S. Subramanyam Sugar coated ceramic nanocarriers for the oral delivery of hydrophobic drugs: formulation, optimalization and evaluation Drug Dev. Ind. Pharm. 38 5 2012 577 586
167. N. Ignjatović, V. Uskoković, Z. Ajduković, and D. Uskoković Multifunctional hydroxyapatite and poly(D,L-lactide-co-glycolide) nanoparticles for the local delivery of cholecalciferol Mater. Sci. Eng. C 33 2013 943 950
168. N. Ignjatović, V. Uskoković, Z. Ajduković, D. Uskoković, Multifunctional nano scale drug delivery particles based on vitamin-3 loaded hydroxyapatite in bone tissue engineering, In: Proceedings of the Yucomat, Fourteen Annual Conference, Herceg Novi, 2012, p. 32.
169. M. Otsuka, and R. Hirano Bone cell activity responsive drug release from biodegradable apatite/collagen nano-composite cements - in vitro dissolution medium responsive vitamin K2 release Colloids Surf. B 85 2011 338 342
170. 2 in rats J. Biomed. Mater. Res. B 79 1 2006 176 184
171. A. Cosijns, C. Vervaet, J. Luyten, S. Mullens, F. Siepmann, L. Van Hoorebeke, B. Masschaele, V. Cnudde, and J.P. Remon Porous hydroxyapatite tablets as carriers for low-dosed drugs Eur. J. Pharm. Biopharm. 67 2007 498 506
172. Q. Zhao, T. Wang, J. Wang, L. Zheng, T. Jiang, G. Cheng, and S. Wang Template-directed hydrothermal synthesis of hydroxyapatite as a drug delivery system for the poorly water-soluble drug carvedilol Appl. Surf. Sci. 257 2011 10126 10133
173. T. Suzuki, K. Arai, H. Goto, M. Hanano, J. Watanabe, and K. Tomono Dissolution tests for self-setting calcium phosphate cement-containing nifedipine Chem. Pharm. Bull. 50 6 2002 741 743
174. X. Wang, L. Li, W. Huo, L. Hou, Z. Zhao, and W. Li Characterization and stability of tianshinone IIA solid dispersions with hydroxyapatite Materials 6 2013 805 816
175. L. Chen, H. Zhu, S. Yang, B. Zhou, F. You, and X. Yan Nanostructure calcium phosphate carriers for delivery of poor water-soluble drug silybin Mater. Lett. 143 2015 252 255